This technology, now used by Acoustic Magic, has revolutionized microphones. As company co-founder Dr. Acomni had its genesis in an algorithm created by Dr. He wanted to see if new approaches to modification of the surfaces of implant materials could be achieved to improve their lifetimes.
The body uses adenosine to signal inflammation and tissue injury. Jeffrey Schwartz, Princeton chemistry professor, who sought to understand why orthopedic implants often failed after only years of use.
At the end ofATL reacquired many of its programs, including Stedivaze. Having a background in biomedical research, I recognized this discovery as an exciting opportunity to address a critical need among patients who have extremely limited treatment options, which is a guiding principle of our company.
Aeglea Biotherapeutics aeglea-biotherapeutics 0 UniversityofTexasatAustin TX 1 Aeglea is a biotechnology company developing recombinant human enzymes for the treatment of genetic rare diseases and cancers associated with abnormal amino acid metabolism. George Georgiou licensed the intellectual property on two human therapeutic programs from the University of Texas at Austin to a company he founded and self-funded at the seed stage.
Understanding this compound has the potential to unleash therapies to treat heart disease, diabetes, arthritis, cancer and atherosclerosis.
The speaker can move about the room freely and be heard with great clarity. Sorin Draghici, professor of computer science at Wayne State University.
Several of the technologies licensed resulted from National Institutes of Health funding. However, taking protein therapeutics to the clinic requires a very significant investment of time and funding. Biomedical The work conducted at the University of Rochester was supported by research funding from the National Institutes of Health.
The research of senior scientists Dr. John Carlisle Their work was part of a year Department of Energy-funded basic materials science research program in advanced diamond materials.
Harvey Silverman and Dr. Adarza Biosystems is a leading developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and in vitro diagnostics customers.
The story of Aculon begins with the quest of Dr. Draghici and his research team hoped to create a technology that opened a window to view the impact of a drug on an entire organism, essentially creating a roadmap for the potential benefits and pitfalls of any potential drug. Participation in I-Corps allowed them to fully develop their idea and flesh out its commercial value.
Based on more than 20 years of innovative work by Yvonne Paterson, PhD, Professor of Microbiology at the University of Pennsylvania, it has been found that the unique microbe Listeria monocytogenes is capable of stimulating numerous aspects of the immune system simultaneously, coordinating innate, humoral antibody and cellular adaptive immune responses in an extremely effective response to existing cancers and other diseases.
Heart failure occurs in more than 3. They collaborated with business leader Robert Capon to establish a startup company based around University of Virginia patents in this area. Department of Agriculture, the University of Virginia has led research into adenosine, a molecule found in all cells.
Adarza products address broad quantitative analyte detection applications, including cancer biomarkers, drug and vaccine development, allergy, immunology and infectious diseases research.
Pathway-Guide is the first tool in a new generation of pathway analysis technologies available on the market that incorporates the topology of the pathway into the analysis. In collaboration with many different researchers, the company participated in a large number of Small Business Innovation Research grants, thereby enabling basic and translational research with federal funding.
Joel Linden, University of Virginia professor of cardiovascular medicine and Timothy MacDonald, University of Virginia professor of chemistry recognized the power of this research. After being recognized as the best of 27 I-Corps teams, the group founded Acomni.
Johnathan Sprinkle of the University of Arizona. Materials Funding from the National Science Foundation supported the research behind the discoveries and technologies that led to Aculon. For homeowners, Ondo enables them to heat or cool their home based on how much they want to spend on electricity, not just on how comfortable they want to be.A Definition of Life.
The ubiquity of life In earlier chapters we considered the astronomical environment which extraterrestrial lifeforms must cope with. Other galaxies, stars, and countless planets appear amenable, if not perfectly hospitable, to life.
Port Manteaux churns out silly new words when you feed it an idea or two. Enter a word (or two) above and you'll get back a bunch of portmanteaux created by jamming together words that are conceptually related to your inputs.
For example, enter "giraffe" and you'll get back words like "gazellephant" and "gorilldebeest". x Innovation Deficit. Close the Innovation Deficit is an effort by the business, higher education, scientific, and high-tech manufacturing communities who are concerned about cuts and stagnating federal investments in research and higher education at a time when other nations are investing heavily in these areas.Download